Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
Jerusalem, Jerusalem District, Israel The leading representative office of defined Corporate Investor is situated in the Jerusalem. The company was established in Asia in Israel.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Reduxio, BioTime, ElastiMed. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. We can highlight the next thriving fund investment areas, such as Therapeutics, Agriculture.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Israel Innovation Authority, startups are often financed by EASME - EU Executive Agency for SMEs, Israel Healthcare Ventures, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are ShengJing360, iVentures Asia Ltd, Trendlines Group. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, Fresenius Medical Care, National Multiple Sclerosis Society (NMSS).
Speaking about the real fund results, this Corporate Investor is 27 percentage points more often commits exit comparing to other organizations. This Israel Innovation Authority works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2017. Deals in the range of 1 - 5 millions dollars are the general things for fund. The top amount of exits for fund were in 2019. The fund is generally included in 7-12 deals every year.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enzymit | $500K | 01 Nov 2022 | Ness Ziona, HaMerkaz, Israel | ||
Navina | 27 Oct 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | |||
BioBetter | $10M | 07 Sep 2022 | Qiryat Shmona, HaZafon, Israel | ||
SuperMeat | 08 Jun 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | |||
VALFIX Medical | 06 Jun 2022 | Tel Aviv-Yafo, Tel Aviv District, Israel | |||
Brevel | 02 Jun 2022 | Israel, North District, Israel | |||
Enlivex Therapeutics | $1M | 25 May 2022 | Israel, North District, Israel | ||
BeautAI | $600K | 01 Apr 2022 | Austin, Texas, United States | ||
Cybord | $4M | 08 Mar 2022 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
